Skip to main content

TG Therapeutics, Inc.

TGTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001001316

In the last 90 days, TG Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 431 institutions reported holding it in 13F filings for Q2 2026, worth $6.10B in total; no superinvestor holds it.

13F holders, Q3 2024

Institutional positions in TG Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
308
+53 vs. Q2 2024
Shares held
101.7M
+19.6M (+23.8%) vs. Q2 2024
Total value
$2.38B
+$919.3M (+63.0%) vs. Q2 2024
New holders
97
93 more added
Sold out
44
74 more reduced

4 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TGTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 308 institutions
Q1 2021: 240 institutionsQ2 2021: 237 institutionsQ3 2021: 223 institutionsQ4 2021: 194 institutionsQ1 2022: 181 institutionsQ2 2022: 175 institutionsQ3 2022: 183 institutionsQ4 2022: 198 institutionsQ1 2023: 214 institutionsQ2 2023: 244 institutionsQ3 2023: 236 institutionsQ4 2023: 236 institutionsQ1 2024: 241 institutionsQ2 2024: 259 institutionsQ3 2024: 308 institutionsQ4 2024: 331 institutionsQ1 2025: 376 institutionsQ2 2025: 356 institutionsQ3 2025: 354 institutionsQ4 2025: 352 institutionsQ1 2026: 365 institutionsQ2 2026: 431 institutions
Value heldQ3 2024: $2.38B
Q1 2021: $4.77BQ2 2021: $3.73BQ3 2021: $3.21BQ4 2021: $1.90BQ1 2022: $960.0MQ2 2022: $452.6MQ3 2022: $594.6MQ4 2022: $1.11BQ1 2023: $1.43BQ2 2023: $2.19BQ3 2023: $756.4MQ4 2023: $1.55BQ1 2024: $1.38BQ2 2024: $1.66BQ3 2024: $2.38BQ4 2024: $2.92BQ1 2025: $3.90BQ2 2025: $3.65BQ3 2025: $3.58BQ4 2025: $3.07BQ1 2026: $3.50BQ2 2026: $6.10B
Institutions holding TGTX and their total value by quarter
QuarterHoldersValue
Q2 2026431$6.10B
Q1 2026365$3.50B
Q4 2025352$3.07B
Q3 2025354$3.58B
Q2 2025356$3.65B
Q1 2025376$3.90B
Q4 2024331$2.92B
Q3 2024308$2.38B
Q2 2024259$1.66B
Q1 2024241$1.38B
Q4 2023236$1.55B
Q3 2023236$756.4M
Q2 2023244$2.19B
Q1 2023214$1.43B
Q4 2022198$1.11B
Q3 2022183$594.6M
Q2 2022175$452.6M
Q1 2022181$960.0M
Q4 2021194$1.90B
Q3 2021223$3.21B
Q2 2021237$3.73B
Q1 2021240$4.77B

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding TG Therapeutics, Inc.; share changes are against Q2 2024.

Institutions holding TGTX in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Soleus Capital Management, L.P.2,534,540$59.3M4.93%−1,111,022−30.5%Reduced
Goldman Sachs Group Inc2,556,427$59.8M0.01%+471,719+22.6%Added
Woodline Partners LP2,565,322$60.0M0.51%+1,145,788+80.7%Added
Geode Capital Management, LLC3,205,228$75.0M0.01%−1,1620.0%Reduced
Pictet Asset Management Holding SA3,582,583$83.8M0.09%+339,102+10.5%Added
State Street Corp9,094,158$212.7M0.01%+2,398,015+35.8%Added
Vanguard Group Inc15,387,290$359.9M0.01%+1,695,600+12.4%Added
BlackRock, Inc.21,956,197$513.6M0.01%+21,956,197New
Marshall Wace, LLP0$00.00%−2,051,762−100.0%Sold out
Balyasny Asset Management LLC0$00.00%−802,003−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−679,020−100.0%Sold out
Point72 Asset Management, L.P.0$00.00%−585,873−100.0%Sold out
Renaissance Technologies LLC0$00.00%−309,371−100.0%Sold out
Jump Financial, LLC0$00.00%−309,004−100.0%Sold out
Twinbeech Capital LP0$00.00%−252,823−100.0%Sold out
Point72 Europe (London) LLP0$00.00%−160,769−100.0%Sold out
Hudson Bay Capital Management LP0$00.00%−147,100−100.0%Sold out
Connor, Clark & Lunn Investment Management Ltd.0$00.00%−144,648−100.0%Sold out
OrbiMed Advisors LLC0$00.00%−133,200−100.0%Sold out
Bayesian Capital Management, LP0$00.00%−105,567−100.0%Sold out
Strategic Financial Concepts, LLC0$00.00%−29,776−100.0%Sold out
Tudor Investment Corp Et Al0$00.00%−83,092−100.0%Sold out
Pearl River Capital, LLC0$00.00%−54,857−100.0%Sold out
Brevan Howard Capital Management LP0$00.00%−53,190−100.0%Sold out
FIL Ltd0$00.00%−49,907−100.0%Sold out
Concentric Capital Strategies, LP0$00.00%−42,311−100.0%Sold out
Dark Forest Capital Management LP0$00.00%−41,252−100.0%Sold out
Quantitative Investment Management, LLC0$00.00%−39,987−100.0%Sold out
Y-Intercept (Hong Kong) Ltd0$00.00%−35,244−100.0%Sold out
XTX Topco Ltd0$00.00%−22,176−100.0%Sold out
Diametric Capital, LP0$00.00%−20,420−100.0%Sold out
Clear Creek Financial Management, LLC0$00.00%−18,850−100.0%Sold out
Aigen Investment Management, LP0$00.00%−18,464−100.0%Sold out
Norris Financial Group, LLC0$00.00%−14,917−100.0%Sold out
Symphony Financial, Ltd. Co.0$00.00%−11,000−100.0%Sold out
Point72 Asia (Singapore) Pte. Ltd.0$00.00%−10,166−100.0%Sold out
LMR Partners LLP0$00.00%−10,000−100.0%Sold out
Somerset Trust Co0$00.00%−10,000−100.0%Sold out
Quarry LP0$00.00%−6,003−100.0%Sold out
nVerses Capital, LLC0$00.00%−5,800−100.0%Sold out
Optiver Holding B.V.0$00.00%−2,495−100.0%Sold out
Catalyst Funds Management Pty Ltd0$00.00%−2,200−100.0%Sold out
Ashton Thomas Private Wealth, LLC0$00.00%−1,986−100.0%Sold out
Canada Pension Plan Investment Board0$00.00%−1,500−100.0%Sold out
Providence Capital Advisors, LLC0$00.00%−127−100.0%Sold out
Itau Unibanco Holding S.A.0$00.00%−122−100.0%Sold out
Pacific Capital Wealth Advisors, Inc0$00.00%−100−100.0%Sold out
LRI Investments, LLC0$00.00%−100−100.0%Sold out
VisionPoint Advisory Group, LLC0$00.00%−75−100.0%Sold out
ORG Partners LLC0$00.00%−50−100.0%Sold out
Innealta Capital, LLC0$00.00%−41−100.0%Sold out
Parkwood LLC0$00.00%−147,680−100.0%Sold out
BlackRock Inc.––––Not filed
Spotlight Asset Group, Inc.––––Not filed
Emfo, LLC––––Not filed
Benjamin F. Edwards & Company, Inc.––––Not filed